Cargando…

Blood cell morphology and COVID-19 clinical course, severity, and outcome

COVID-19 infection affects different organs of the human body, and blood cells are not an exception. Peripheral blood smear (PBS) is a simple and available method to investigate blood cells’ morphologic changes. In this study, we aimed to determine the morphologic changes and abnormalities of COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pezeshki, Amirhossein, Vaezi, Atefeh, Nematollahi, Pardis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255335/
https://www.ncbi.nlm.nih.gov/pubmed/34249171
http://dx.doi.org/10.1007/s12308-021-00459-3
_version_ 1783717881306939392
author Pezeshki, Amirhossein
Vaezi, Atefeh
Nematollahi, Pardis
author_facet Pezeshki, Amirhossein
Vaezi, Atefeh
Nematollahi, Pardis
author_sort Pezeshki, Amirhossein
collection PubMed
description COVID-19 infection affects different organs of the human body, and blood cells are not an exception. Peripheral blood smear (PBS) is a simple and available method to investigate blood cells’ morphologic changes. In this study, we aimed to determine the morphologic changes and abnormalities of COVID-19 patients and their relation to the patients’ clinical course. In this prospective cross-sectional study, we included 89 PCR-positive COVID-19 patients. A pathologist examined the PBS findings of these patients. The patients’ clinical course, including severity, outcome, intubation, and ICU admission, was extracted from their profiles. The statistical analyses were done to find out the relation between PBS findings and patients’ clinical course. Results showed that smudge cells are the most frequent abnormality in our participants. Other findings were schistocyte; atypical lymphocytes; and increased large granular lymphocytes, shift to left of granulocytes, giant platelets, and leukoerythroblastic reaction. Our results did not show any statistically significant relationship between PBS findings and their clinical course. Although other studies suggested PBS as a possible predictive tool for COVID-19 disease, our study showed that these findings could not predict nor relate to the patients’ clinical course. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12308-021-00459-3.
format Online
Article
Text
id pubmed-8255335
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82553352021-07-06 Blood cell morphology and COVID-19 clinical course, severity, and outcome Pezeshki, Amirhossein Vaezi, Atefeh Nematollahi, Pardis J Hematop Original Article COVID-19 infection affects different organs of the human body, and blood cells are not an exception. Peripheral blood smear (PBS) is a simple and available method to investigate blood cells’ morphologic changes. In this study, we aimed to determine the morphologic changes and abnormalities of COVID-19 patients and their relation to the patients’ clinical course. In this prospective cross-sectional study, we included 89 PCR-positive COVID-19 patients. A pathologist examined the PBS findings of these patients. The patients’ clinical course, including severity, outcome, intubation, and ICU admission, was extracted from their profiles. The statistical analyses were done to find out the relation between PBS findings and patients’ clinical course. Results showed that smudge cells are the most frequent abnormality in our participants. Other findings were schistocyte; atypical lymphocytes; and increased large granular lymphocytes, shift to left of granulocytes, giant platelets, and leukoerythroblastic reaction. Our results did not show any statistically significant relationship between PBS findings and their clinical course. Although other studies suggested PBS as a possible predictive tool for COVID-19 disease, our study showed that these findings could not predict nor relate to the patients’ clinical course. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12308-021-00459-3. Springer Berlin Heidelberg 2021-07-05 /pmc/articles/PMC8255335/ /pubmed/34249171 http://dx.doi.org/10.1007/s12308-021-00459-3 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Pezeshki, Amirhossein
Vaezi, Atefeh
Nematollahi, Pardis
Blood cell morphology and COVID-19 clinical course, severity, and outcome
title Blood cell morphology and COVID-19 clinical course, severity, and outcome
title_full Blood cell morphology and COVID-19 clinical course, severity, and outcome
title_fullStr Blood cell morphology and COVID-19 clinical course, severity, and outcome
title_full_unstemmed Blood cell morphology and COVID-19 clinical course, severity, and outcome
title_short Blood cell morphology and COVID-19 clinical course, severity, and outcome
title_sort blood cell morphology and covid-19 clinical course, severity, and outcome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255335/
https://www.ncbi.nlm.nih.gov/pubmed/34249171
http://dx.doi.org/10.1007/s12308-021-00459-3
work_keys_str_mv AT pezeshkiamirhossein bloodcellmorphologyandcovid19clinicalcourseseverityandoutcome
AT vaeziatefeh bloodcellmorphologyandcovid19clinicalcourseseverityandoutcome
AT nematollahipardis bloodcellmorphologyandcovid19clinicalcourseseverityandoutcome